• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Opinion

Video

A Conversation on Combination Therapy, Safety Profiles, and Targeted IL-17 Systemic Treatments

Author(s):

Alexa Hetzel, MS, PA-C,Andrew Mastro, MS, PA-C

The experts discuss combination therapy approaches, safety considerations, and targeted interleukin-17 systemic treatments for plaque psoriasis.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
Takeda Targets Clinical Disparities in Psoriasis Research
March 5th 2025

Takeda Targets Clinical Disparities in Psoriasis Research

The Cutaneous Connection: An Inside Look of the Inclusive Atlas
November 4th 2021

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

A “Step-Down” Approach May Be More Effective for Younger Patients with Psoriasis
February 27th 2025

A “Step-Down” Approach May Be More Effective for Younger Patients with Psoriasis

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
September 23rd 2021

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

Nail Diseases in Skin of Color: A Research Gap
February 20th 2025

Nail Diseases in Skin of Color: A Research Gap

5-Year Study Backs Deucravacitinib’s Safety and Efficacy
February 19th 2025

5-Year Study Backs Deucravacitinib’s Safety and Efficacy

© 2025 MJH Life Sciences

All rights reserved.